Prelude Capital Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
AIM
CII
CS
NAMA
B
Prelude Capital Management's CLLS Position: Q3 2020 in Review
Prelude Capital Management sold out of Cellectis (CLLS) in Q3 2020, closing a stake of 3,600 shares — an estimated $64K sold.
Prelude Capital Management first reported a position in CLLS in Q1 2015 and held it in 15 quarters. The position peaked at $127K in Q2 2017. 74 funds tracked by Wall St. Rank hold CLLS as of Q3 2020.
- Prelude Capital Management reported no remaining Cellectis position as of Q3 2020 after selling out during the quarter.
- Prelude Capital Management sold 3,600 Cellectis shares in Q3 2020, an estimated $64K.
- Prelude Capital Management first reported a position in Cellectis in Q1 2015 and held it in 15 quarters.
- Prelude Capital Management's Cellectis position peaked at $127K in Q2 2017.
- 74 funds tracked by Wall St. Rank held Cellectis as of Q3 2020.
Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.